Catalyst Wire Dossier Catalyst Wire Dossier

Rosuampin Tablet

Rosuampin · Yuhan Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rosuampin Tablet, covering 2025-01-22 to 2025-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia

See pricing